FMP
Precipio, Inc.
PRPO
NASDAQ
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD PCR, a proprietary and patented specimen technology that increases the sensitivity of molecular based tests; and COVID-19 antibody tests. It sells ICE-COLD-PCR technology kits to bio-pharma customers. Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment. The company is based in New Haven, Connecticut.
5.05 USD
-0.19 (-3.76%)
Historical Prices
From:
To:
We are unable to load the chart at this time.
About
ceo
Mr. Ilan Danieli
sector
Healthcare
industry
Medical - Diagnostics & Research
website
https://www.precipiodx.comexchange
NASDAQ
Description
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD PCR, a proprietary and patented specimen technology that increases the sensitivity of molecular based tests; and COVID-19 antibody tests. It sells ICE-COLD-PCR technology kits to bio-pharma customers. Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment. ...
CIK
0001043961
ISIN
US74019L6020
CUSIP
74019L503
Address
4 Science Park
Phone
203 787 7888
Country
US
Employee
51
IPO Date
Jun 30, 2017
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
PRPO Financial Summary
CIK
0001043961
Exchange
NASDAQ
Industry
Medical - Diagnostic...
Sector
Healthcare
CUSIP
74019L503
ISIN
US74019L6020
Country
US
Price
5.05
Beta
1.42
Volume Avg.
6.99k
Market Cap
7.49M
Shares
-
52-Week
4.31-7.3
DCF
-0.37
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-2.79
P/B
-
Website
https://www.precipiodx.com
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest PRPO News
It looks like there's no news available.
